| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.9 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.9 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | 0.022 | 0.9 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | 0.022 | 0.9 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | 0.02 | 0.9 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.9 |